Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7343 p383
2 April 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Contract 2005


Many independents unprepared for new contract

Many independent community pharmacists are not prepared for the new community pharmacy contract, according to Avicenna, which presented results from a survey at its annual conference in Sorrento, Italy, last week.

The buying group sent a questionnaire to its members and carried out 40 in-depth interviews by telephone. Almost 70 per cent of members believed they would need to refit their pharmacy to comply with the new contract. At present, only 33 per cent who answered had a consultation area and only 51 per cent knew what the requirements for consultation areas were.

In addition, most members did not know what their primary care trusts’ strategies for implementing the new contract were and only 40 per cent of members knew whether there were plans for local improvement finance trust (LIFT) programmes (such as super surgeries or health centres) in their area.

Speaking at the conference, Salim Jetha, chairman of Avicenna, said that there was a lack of preparation for the changes facing pharmacists and that, while members were concerned about this, there was a lack of enthusiasm to tackle the issue. “Change is happening fast in community pharmacy, but pharmacists are not changing their focus to keep pace with it,” he said. He also outlined a number of training programmes and resources that Avicenna is setting up to help its members overcome some of these difficulties.

Commenting on the survey results, Stephen Lutener, head of regulation at the Pharmaceutical Services Negotiating Committee, said: “As we approach implementation on 1 April 2005, pharmacy contractors will be in varying states of preparedness, but will have a transitional period of six months in which to make amendments to meet the requirements of the ‘essential services’ tier.”

Back to Top


©The Pharmaceutical Journal